Novavax
NVAX
#5390
Rank
A$2.10 B
Marketcap
A$12.97
Share price
11.87%
Change (1 day)
-6.72%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.60 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.02 Billion. In 2024 the company made an earning of -A$0.24 Billion, an increase over its 2023 earnings that were of -A$0.8 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.60 B-359.97%
2024 -A$0.24 Billion-70.39%
2023 -A$0.8 Billion-16.59%
2022 -A$0.95 Billion-62.58%
2021 -A$2.54 Billion320.54%
2020 -A$0.61 Billion234.22%
2019 -A$0.19 Billion-30.17%
2018 -A$0.26 Billion1.69%
2017 -A$0.26 Billion-36.44%
2016 -A$0.4 Billion70.4%
2015 -A$0.24 Billion89.27%
2014 -A$0.13 Billion59.83%
2013 -A$77.5 Million81.9%
2012 -A$42.61 Million50.33%
2011 -A$28.34 Million
2009 -A$55.93 Million8.8%
2008 -A$51.41 Million18.01%
2007 -A$43.56 Million18.33%
2006 -A$36.82 Million168.31%
2005 -A$13.72 Million-62.51%
2004 -A$36.6 Million52.4%
2003 -A$24.02 Million-28.21%
2002 -A$33.46 Million
2000 -A$19.07 Million177%
1999 -A$6.89 Million-11.54%
1998 -A$7.78 Million10.64%
1997 -A$7.04 Million-9.62%
1996 -A$7.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
A$30.91 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-A$0.38 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.24 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.9 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.58 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
A$17.73 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.56 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-A$12.16 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$13.94 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-A$0.39 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA